Literature DB >> 24090973

Impact of delineation uncertainties on dose to organs at risk in CT-guided intracavitary brachytherapy.

Frances K Duane1, Brian Langan2, Charles Gillham3, Lorraine Walsh3, Guhan Rangaswamy3, Ciara Lyons3, Mary Dunne4, Christopher Walker2, Orla McArdle3.   

Abstract

PURPOSE: This study quantifies the inter- and intraobserver variations in contouring the organs at risk (OARs) in CT-guided brachytherapy (BT) for the treatment of cervical carcinoma. The dosimetric consequences are reported in accordance with the current Gynecological Groupe Européen de Curiethérapie/European Society for Therapeutic Radiology and Oncology guidelines. METHODS AND MATERIALS: A CT planning study of 8 consecutive patients undergoing image-guided BT was conducted. The bladder, rectum, and sigmoid were contoured by five blinded observers on two identical anonymized scans of each patient. This provided 80 data sets for analysis. Dosimetric parameters analyzed were D0.1 cc, D1 cc, and D2 cc. The mean volume of each OAR was calculated. These endpoints were compared between and within the observers. The CT image sets from all patients were evaluated qualitatively.
RESULTS: The interobserver coefficient of variation for reported D2 cc was 13.2% for the bladder, 9% for the rectum, and 19.9% for the sigmoid colon. Unlike the variation seen in bladder and rectal contours, which differed largely in localization of the organ walls on individual slices, sigmoid colon contours demonstrated large differences in anatomic interpretation.
CONCLUSIONS: Variation in recorded D2 cc to the bladder and rectum is comparable with the previous published results. Inter- and intraphysician variations in reported D2 cc is high for the sigmoid colon, reflecting varying interpretation of sigmoid colon anatomy. Variation in delineation of the OARs may influence treatment optimization and is a potential source of uncertainty in the image-guided BT planning and delivery process.
Copyright © 2014 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Delineation variation; Image-guided brachytherapy; Organs at risk

Mesh:

Year:  2013        PMID: 24090973     DOI: 10.1016/j.brachy.2013.08.010

Source DB:  PubMed          Journal:  Brachytherapy        ISSN: 1538-4721            Impact factor:   2.362


  7 in total

1.  A Feasibility Study of Deep Learning-Based Auto-Segmentation Directly Used in VMAT Planning Design and Optimization for Cervical Cancer.

Authors:  Along Chen; Fei Chen; Xiaofang Li; Yazhi Zhang; Li Chen; Lixin Chen; Jinhan Zhu
Journal:  Front Oncol       Date:  2022-06-01       Impact factor: 5.738

2.  An evaluation of the robustness of organ-at-risk recommendations made by GEC/ESTRO according to interobserver variability: a single-center experience.

Authors:  Rodolfo Chicas-Sett; Francisco Celada-Alvarez; Susana Roldán; Asunción Torregrosa; Jesus Betancourt; Juan Bautista-Ballesteros; Dolores Farga; Blanca Ibañez; Alejandro Tormo; Jose Perez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2016-08-16

3.  Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy.

Authors:  Primoz Petric; Robert Hudej; Noora Al-Hammadi; Barbara Segedin
Journal:  Radiol Oncol       Date:  2016-11-09       Impact factor: 2.991

4.  Statistical Analysis of Interfraction Dose Variations of High-Risk Clinical Target Volume and Organs at Risk for Cervical Cancer High-Dose-Rate Brachytherapy.

Authors:  Brien Washington; Marcus Randall; Denise Fabian; Dennis Cheek; Chi Wang; Wei Luo
Journal:  Adv Radiat Oncol       Date:  2022-07-19

5.  New target volume delineation and PTV strategies to further personalise radiotherapy.

Authors:  David Bernstein; Alexandra Taylor; Simeon Nill; Uwe Oelfke
Journal:  Phys Med Biol       Date:  2021-02-25       Impact factor: 3.609

6.  Potential role of TRAns Cervical Endosonography (TRACE) in brachytherapy of cervical cancer: proof of concept.

Authors:  Primoz Petric; Christian Kirisits
Journal:  J Contemp Brachytherapy       Date:  2016-06-13

7.  Inter-observer and intra-observer variability in reporting vaginal dose points for cervical cancer in high-dose-rate brachytherapy.

Authors:  Nuria Carrasco; Jose Chimeno; Mar Adrià-Mora; María José Pérez-Calatayud; Blanca Ibáñez; Vicente Carmona; Francisco Celada; Jose Gimeno; Françoise Lliso; José Pérez-Calatayud
Journal:  J Contemp Brachytherapy       Date:  2020-04-17
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.